Economics of helicobacter pylori eradication therapy

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue SUPPL.1, 2012, Pages

  Deltenre, Michel A L ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Helicobacter pylori; peptic ulcer disease

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; TINIDAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; STOMACH SECRETION INHIBITOR;

ARTICLE; COST BENEFIT ANALYSIS; ENDOSCOPY; ERADICATION THERAPY; EUROPE; HEALING; HEALTH CARE COST; HELICOBACTER INFECTION; HUMAN; INFECTION RISK; MAINTENANCE THERAPY; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; CONFERENCE PAPER; DEVELOPED COUNTRY; DIGESTIVE TRACT ENDOSCOPY; GRAM NEGATIVE INFECTION; HEALTH ECONOMICS; HELICOBACTER PYLORI; RELAPSE; STOMACH ACID SECRETION; UNITED STATES; WESTERN EUROPE;

COST-BENEFIT ANALYSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0030994583     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-201204001-00006     Document Type: Article

References (22)

1. Sonnenberg A: Costs of medical and surgical treatment of duodenal ulcer. Gastroentcrology 1989, 96:1445-1452. (Pubitemid 19138685)
2. Ruszniewski P: Pharmaco-economic considerations in the longterm management of peptic ulcer disease. Ailment Pharrnacol Ther 1991, 7 (suppl 2):41-48. (Pubitemid 23198352)
3. Metropolitan Insurance Company: Peptic ulcer medication usage. Stat Bull 1990, 71:10-17.
4. Bloom BS: Cross-national changes in the effects of peptic ulcer disease. Ann Intern Med 1991, 114:558-562.
5. Sonnenberg A, Townsend WF: Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med 1995,155:922-928.
6. Olson AD, Deutsch D, Louis-Jacques O, et al.: Clinical and economic analysis of immediate endoscopy, serological screening for Helicobacter pylori and empiric treatment of Helicobacter pylori for pediatric patients with dyspepsia [abstract]. Gastroenterology 1995, 109:A432.
7. Bytzer P, Hansen JM, Schaffalitzky de Muchadell OB: Empirical l-12-blocker therapy or prompt endoscopy in management of dyspepsi. Lancct 1994, 343:811-816. (Pubitemid 24147509)
8. Malferthiner P, Mégraud F, O'Morain C, et al.: Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Eur J Gastroentervl Hepatol 1997. 9:1-2. (Pubitemid 27047348)
9. Greenberg PD, Koch J, Cello JP: The clinical utility and cost- effectiveness of testing Helicobacter pyloni in patients with duodenal ulcers [abstract]. Gastroenterology 1995, 109:A459
10. McCort JT, Fendrick AM: Management of patients with known duodenal ulcer disease but unknown Helicobacter pylori status [abstract]. Gastroenterology 1995, 109:A50.
11. Unge P, Jonsson B, StSlhammar NO: The cost-effectiveness of Helicvbacter pylori eradication vs maintenance and episodic treatment in duodenal ulcer patients in Sweden. Pharmacoeconomics 1995, 8:410-427.
12. Mulder C, Schipper D: Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials. Scand J Gastroenterol 1990, 25 (suppl 178):62-66.
13. Hawkey CJ, Long RG, Bardham KD, et al.: Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993, 34:1458-1462. (Pubitemid 23293640)
14. Crowe, JP, Keeling PWN, Bate CM, Taylor MD, Richardson PDI: Speed of symptom relief and predictability of healing in duodenal ulcer disease: a comparison of omeprazole 20 mg with ranitidine 300 mg daily. Omeprazole 40 mg daily provides additional benefit in patients with an incomplete response. Eur J Clin Res 1994, 5:141-150.
15. Jonsson B, Drummond MF:Cost-effectiveness of omepraiole and ranitidine in the treatment of duodenal ulcer. Pharmacoeconomics 1994, 5 (suppl 3):44-55.
16. Bazzoli F, Zagari RM, Fossi S, et al.: Short-term low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994, 6:773-777. (Pubitemid 24261052)
17. Logan RPH, Gummet PA, Hegarty BT, Walker MM, Baron JH, Misiewicz JJ: Clarithromycin and omeprazole for Helicobacter pylori. Lancet 1992, 340 :239.
18. Deltenre M, Jonas C, van Gossum M, Buset M, Otero J, De Koster E: Omeprazole-based antimicrobial therapies: results in 198 Helicobac for pylori-positive patients. Eur J Gastroenterol Hepatol 1995,7 (suppl 1):S39-S44.
19. Goddard A, Logan R: One-week low-dose triple therapy: new standards for Helicoba cter pylori treatment. Eur J Gastroenterol Hepatol 1995, 7:1-3.
20. Ashton T: Cost effectiveness of alternative medication in the treatment of duodenal ulcer. Scand J Gastroenterol 1991, 26: 82-88.
21. Festen HPM: Prevention of duodenal ulcer relapse by long-term treatment with omeprazole. Scand J Gastroenterol 1994, 29 (suppl 201):39-41 (Pubitemid 24165473)
22. Penston JG: Helicobacter pylori eradication: understandable caution but no excuse for inertia. Ailment Pharmacol Ther 1994, 8:369-389. (Pubitemid 24257553)